Skip to main navigation menu Skip to main content Skip to site footer
Academia Open

Medicine

Vol 9 No 2 (2024): December

Hyperglycemia and Cholesterol Surge in Iraqi Diabetic Patients
Hiperglikemia dan Lonjakan Kolesterol pada Pasien Diabetes di Irak



(*) Corresponding Author
DOI
https://doi.org/10.21070/acopen.9.2024.9087
Published
May 31, 2024

Abstract

Diabetes mellitus, a metabolic disorder characterized by abnormal hyperglycemia, often correlates with dyslipidemia. This study examined the relationship between random blood sugar (RBS) levels and cholesterol types (HDL, LDL, and total cholesterol) in 350 patients from Diyala, collected between February and April 2023. Results showed higher blood sugar levels in females (22.3%) than males (19.7%) among the elderly (≥60 years). Type 2 diabetes was more prevalent than type 1 (77% vs. 5.4%). Cholesterol levels were elevated in 26% of patients. RBS was high in 82% of patients, and 49% had elevated total cholesterol. Both age groups 41-60 and ≥60 had high hyperglycemia incidence (32%), with higher prevalence in females (40.6%) compared to males (35.7%). These findings underscore the need for targeted interventions to manage blood sugar and cholesterol levels.

Highlights:

  • Prevalence: Type 2 diabetes is significantly more common than type 1 among patients in Diyala.
  • Gender Disparity: Females exhibit higher blood sugar and cholesterol levels compared to males.
  • Age Impact: Elevated blood sugar is prevalent in both middle-aged and elderly populations, necessitating targeted interventions.

Keywords: Diabetes Mellitus, Hyperglycemia, Cholesterol, Insulin Resistance, Dyslipidemia

References

  1. W. H. Herman, "Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030," Diabetes Care, vol. 38, no. 8, pp. 1665-1673, 2015. Accessed: Aug. 26, 2021.
  2. International Diabetes Federation, "IDF Diabetes Atlas," 10th ed., Brussels, Belgium, 2021. Accessed: Jan. 3, 2022. [Online]. Available: https://www.diabetesatlas.org/atlas/tenth-edition/
  3. M. Baalbaki and R. Baalbaki, Al-Mawrid Al-Hadith (in Arabic and English), 1st ed., Beirut, Lebanon: Dar Al-Ilm Lilmalayin, 2008, p. 219. ISBN: 978-9953-63-541-5.
  4. American Diabetes Association, "Standards of Medical Care in Diabetes," Diabetes Care, vol. 35, no. 1, pp. 11-63, 2012.
  5. I. Penman, S. Ralston, M. Strachan, and R. Hobson, Davidson's Principles and Practice of Medicine, 23rd ed., London, UK: Elsevier, 2018, pp. 722-740.
  6. R. R. Hamid, O. R. Hamid, N. M. Thabet, and N. E. Abdel-Razzaq, "A Biochemical Study of Liver Function in Type 2 Diabetes Patients With Arterial Hypertension," Anbar University Journal, vol. 7, 2013, pp. 1991-8941.
  7. P. M. Ridker et al., "Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein," N Engl J Med., vol. 359, pp. 2195-2207, 2008.
  8. Cholesterol Treatment Trialists' (CTT) Collaborators, "Efficacy of Cholesterol-Lowering Therapy in 18,686 People With Diabetes in 14 Randomised Trials of Statins: A Meta-Analysis," Lancet, vol. 371, pp. 117-125, 2008.
  9. B. G. Drew, K. A. Rye, S. J. Duffy, P. Barter, and B. A. Kingwell, "The Emerging Role of HDL in Glucose Metabolism," Nat Rev Endocrinol., vol. 8, pp. 237-245, 2012.
  10. Global Burden of Disease Collaborative Network, "Global Burden of Disease Study 2019 Results," Institute for Health Metrics and Evaluation, 2020. [Online]. Available: https://vizhub.healthdata.org/gbd-results/
  11. R. K. Avramoglu, H. Basciano, and K. Adeli, "Lipid and Lipoprotein Dysregulation in Insulin Resistant States," Clin Chim Acta., vol. 368, pp. 1-19, 2006.
  12. P. E. Wandell and A. C. Carlsson, "Microvascular Complications of Type 2 Diabetes Mellitus," Curr Diabetes Rev., vol. 9, no. 4, pp. 342-349, 2013.
  13. C. Faselis, A. Katsimardou, K. Imprialos, P. Deligkaris, M. Kallistratos, and K. Dimitriadis, "Microvascular Complications of Type 2 Diabetes Mellitus," Curr Vasc Pharmacol., vol. 18, pp. 117-124, 2020. doi: 10.2174/1570161117666190502103733.
  14. M. A. Umans-Eckenhausen, E. J. Sijbrands, J. J. Kastelein, and J. C. Defesche, "Low-Density Lipoprotein Receptor Gene Mutations and Cardiovascular Risk in a Large Genetic Cascade Screening Population," Circulation, vol. 106, pp. 3031-3036, 2002.
  15. N. Sattar et al., "Statins and Risk of Incident Diabetes: A Collaborative Meta-Analysis of Randomised Statin Trials," Lancet, vol. 375, pp. 735-742, 2010.
  16. C. C. Low Wang, C. N. Hess, W. R. Hiatt, and A. B. Goldfine, "Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations," Circulation, vol. 133, no. 24, pp. 2459-2502, 2016.
  17. S. D. de Ferranti et al., "Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association," Diabetes Care, vol. 37, no. 10, pp. 2843-2863, 2014.

Downloads

Download data is not yet available.